Amphotericin B- and fluconazole-resistant Candida spp., Aspergillus fumigatus, and other newly emerging pathogenic fungi are susceptible to basic antifungal peptides.
about
Two functional motifs define the interaction, internalization and toxicity of the cell-penetrating antifungal peptide PAF26 on fungal cellsHost-defense peptides with therapeutic potential from skin secretions of frogs from the family pipidaePeptide-based Antifungal Therapies against Emerging Infections.Candidacidal activity of synthetic peptides based on the antimicrobial domain of the neutrophil-derived protein, CAP37The human salivary peptide histatin 5 exerts its antifungal activity through the formation of reactive oxygen species.Histatin 3-mediated killing of Candida albicans: effect of extracellular salt concentration on binding and internalizationIn vitro assessment of antifungal therapeutic potential of salivary histatin-5, two variants of histatin-5, and salivary mucin (MUC7) domain 1.Unusual susceptibility of a multidrug-resistant yeast strain to peptidic antifungals.Protection of the oral mucosa by salivary histatin-5 against Candida albicans in an ex vivo murine model of oral infection.Complementation of a Saccharomyces cerevisiae ERG11/CYP51 (sterol 14α-demethylase) doxycycline-regulated mutant and screening of the azole sensitivity of Aspergillus fumigatus isoenzymes CYP51A and CYP51B.Anti-candidal activity of genetically engineered histatin variants with multiple functional domainsInfluence of histatin 5 on Candida albicans mitochondrial protein expression assessed by quantitative mass spectrometry.Antimicrobial peptides in the oral environment: expression and function in health and disease.Histatin 5 resistance of Candida glabrata can be reversed by insertion of Candida albicans polyamine transporter-encoding genes DUR3 and DUR31.Susceptibility of Candida dubliniensis to salivary histatin 3.The P-113 fragment of histatin 5 requires a specific peptide sequence for intracellular translocation in Candida albicans, which is independent of cell wall binding.Resistance of Porphyromonas gingivalis ATCC 33277 to direct killing by antimicrobial peptides is protease independentDevelopment and In Vivo Evaluation of a Novel Histatin-5 Bioadhesive Hydrogel Formulation against Oral Candidiasis.Histatin 5-spermidine conjugates have enhanced fungicidal activity and efficacy as a topical therapeutic for oral candidiasis.How does it kill?: understanding the candidacidal mechanism of salivary histatin 5.Typing of Candida glabrata in clinical isolates by comparative sequence analysis of the cytochrome c oxidase subunit 2 gene distinguishes two clusters of strains associated with geographical sequence polymorphisms.Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5.Rapid Screening of Antimicrobial Synthetic Peptides
P2860
Q27318277-B8838E64-4FAA-4EAB-A1BC-76A038851394Q28659477-DB4D9CF6-EC21-40A5-9788-21B80DB0B9A6Q33862289-3A7BA946-4999-431C-9A3E-A267DF2039E1Q33927464-5379E1D5-06B1-4A89-81B9-C6C1814B2443Q33952105-D7EF2BA1-BDBC-4EF6-AFA2-ADC77733E698Q33977671-4C8FA9AA-0B27-4340-AB70-81F9CCF463B7Q33979652-27D50E9F-4514-4565-87F8-423F494CBA9EQ33981198-C58EF1F6-ADFB-475D-BC34-47B9F5CF5954Q34067033-27BDE1A5-78B6-46C4-A06B-F3CF7809D3BCQ34290082-C271876E-09DD-4815-90F2-3191CE7724C2Q34516733-F0302B5F-046D-4830-9A6F-8468953D81A9Q34553406-88CF4E9E-0BB1-4B4B-BF3D-BC00FC09C8B9Q34684398-1C6E4188-8D1E-4E62-9F35-DA7CF94259E5Q34684434-71C3EFDB-7405-46CD-94D0-11FDB85BF10FQ34722920-821E05D7-7CCA-4A27-A05D-5BA64813ECFEQ36424968-B7AE22D0-8392-4CCE-A3DA-B0C149340475Q36425009-A13B772F-2A0F-4C49-9B90-29ADB213BA72Q36571953-E40AB8A2-FC4B-4196-A83F-EF160C32114AQ37544689-A61C38AA-E6B6-4526-9A52-833A01F6AC03Q38222086-458A2435-8FA6-4704-A99D-766D625E1454Q39468019-48B7D474-2211-400D-925B-840193DB425EQ39477082-A4EC815B-7F8E-43C7-B3DC-E1D986D66C98Q40935440-D09E3DD4-CC81-43C3-8716-6864AE018EE5
P2860
Amphotericin B- and fluconazole-resistant Candida spp., Aspergillus fumigatus, and other newly emerging pathogenic fungi are susceptible to basic antifungal peptides.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Amphotericin B- and fluconazol ...... to basic antifungal peptides.
@en
Amphotericin B- and fluconazol ...... to basic antifungal peptides.
@nl
type
label
Amphotericin B- and fluconazol ...... to basic antifungal peptides.
@en
Amphotericin B- and fluconazol ...... to basic antifungal peptides.
@nl
prefLabel
Amphotericin B- and fluconazol ...... to basic antifungal peptides.
@en
Amphotericin B- and fluconazol ...... to basic antifungal peptides.
@nl
P2093
P2860
P1476
Amphotericin B- and fluconazol ...... to basic antifungal peptides.
@en
P2093
A V Amerongen
E C Veerman
E J Helmerhorst
I M Reijnders
I Simoons-Smit
W van't Hof
P2860
P304
P407
P577
1999-03-01T00:00:00Z